Locations:
Search IconSearch

Researchers Discover Differences in Protein Makeup of Male vs. Female Retinas

Preclinical study shows why it’s critical to consider sex in eye disease research

A woman's eye next to a man's eye

Researchers at Cleveland Clinic Cole Eye Institute have published a first-of-its-kind database of sex-based differences in the retina and retinal pigment epithelium (RPE).

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

The preclinical study, published in Biology of Sex Differences, illustrates why it is critical to consider sex in research around eye disease, says senior author Bela Anand-Apte, MBBS, PhD, MBA, Chair of Ophthalmic Research at the Cole Eye Institute.

Sex as a risk factor for eye disease

Research on sex as a risk factor for age-related macular degeneration has been controversial, with a few studies showing higher prevalence in older women. In addition, preclinical studies consistently demonstrate that males are at higher risk of developing diabetes-related retinopathy when compared with females. The exact mechanisms behind these differences are unclear.

“It is commonly believed that if you manage your diabetes, you avoid diabetic retinopathy, but many people who have good control of their diabetes still get damage to their retina and RPE,” Dr. Anand-Apte says. “The fact that females seem to be more resistant to diabetic retinopathy was intriguing and inspired me to start at square one, before the disease even begins.”

Comparing number of proteins

Dr. Anand-Apte teamed up with Belinda Willard, PhD, Director of Cleveland Clinic's Proteomics and Metabolomics Core, to see if there were differences between sexes within the proteome, the entire set of proteins produced in the retina and RPE.

Most researchers will use qualitative proteomics to look for proteins that are either present or absent in one group. Drs. Anand-Apte and Willard performed quantitative proteomics, which can quantify differences in the number of proteins between samples.

“Dr. Willard’s team was essential in making this research happen — we couldn’t have done it anywhere else,” Dr. Anand-Apte says. “In fact, few researchers have this capability.”

Advertisement

The research team discovered that there are innate differences in the protein makeup of RPE and retinal cells between male and female preclinical models. There were 21 differentially expressed proteins in the retina, signaling differentially activated pathways, such as nucleotide excision repair, molecular transport, and cell death and survival. There were 58 differentially expressed proteins in the RPE, signaling differentially activated pathways, such as calcium signaling, actin cytoskeletal signaling, and cellular assembly and organization.

Next step: Exploring differences in eye disease progression

These data will help Dr. Anand-Apte and her team investigate their next question: Can we connect differences in how eye disease progresses to these baseline differences in proteins?

“These data are meant to be a tool for the research community to identify the reasons behind discrepancies in how eye disease progresses,” Dr. Anand-Apte says. “We’re beginning to gather the clues necessary for personalized treatment.”

Advertisement

Related Articles

23-EYE-4196362-inflammation-retinal-regeneration-CQD-Hero
Could Inflammation Be the Reason Why Human Retinas Don’t Regenerate?

Researchers to study retinal regeneration in zebrafish with new grant from National Eye Institute

An eye with keratoconus
Where to Look for the Earliest Indication of Subclinical Keratoconus

Motion-tracking Brillouin microscopy pinpoints corneal weakness in the anterior stroma

Child wearing a virtual reality headset
Real-World Evidence Supports Dichoptic Therapy for Amblyopia

Registry data highlight visual gains in patients with legal blindness

Pregnant woman in a pharmacy
Managing Glaucoma in Pregnant Patients

Prescribing eye drops is complicated by unknown risk of fetotoxicity and lack of clinical evidence

Using heads-up display during retina surgery
Imaging in the OR: Combining Intraoperative OCT With Heads-Up Display

A look at emerging technology shaping retina surgery

microinvasive glaucoma surgery
How to Get Started With Microinvasive Glaucoma Surgery (Part 1)

7 keys to success for comprehensive ophthalmologists

Eye with uveitis
Patients Taking GLP-1 Meds Reduce Risk of Noninfectious Uveitis by About 50%

Study is first to show reduction in autoimmune disease with the common diabetes and obesity drugs

Ad